my life is a musical limited liability company

311 w. 43rd street
suite 605
new york, new york 10036

NYS Entity Status
ACTIVE

NYS Filing Date
SEPTEMBER 26, 2013

NYS DOS ID#
4464393

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - MY LIFE IS A MUSICAL LIMITED LIABILITY COMPANY









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Upstate NY’s Basilica Soundscape Is A Festival Of Intimate Juxtaposition: Pastoral Stillness, Frenetic Noise
    By Caitlin White - Tuesday Sep 19, 2017

    An LA native travels to Hudson, New York for one of the most intimate, noisiest and most picturesque festivals in the country

    Source: Uproxx
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Wife of Las Vegas massacre victim: ‘He saved my life and lost his’
    By Ruth Brown - Monday Oct 2, 2017

    A male nurse from Tennessee was among the 50 people killed in the mass shooting at a Las Vegas music concert Sunday night, according to a report. Sonny Melton was fatally gunned down at the Route 91 music festival when shooter Stephen Paddock opened fire on the crowd, his wife told radio station WCYB reports....

    Source: New York Post: News
  • Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
    By Deadline - Tuesday Jul 25, 2017

    The film will go into limited release December 1.

    Source: New York Post: Entertainment
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York